Philip I - Search Results

1

Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988.

Favrot MC, Coze C, Combaret V, Philip I, Philip T, Gaspard M, Negrier S, Franks CR. Favrot MC, et al. Among authors: philip i, philip t. Cancer Res. 1989 Aug 1;49(15):4369. Cancer Res. 1989. PMID: 2743327 No abstract available.

2

Lymphokine-activated killer cell expansion for clinical trials of adoptive immunotherapy with interleukin-2: optimization of the culture technique.

Favrot MC, Coze C, Combaret V, Gaspard M, Colin C, Franks C, Negrier S, Philip I, Philip T. Favrot MC, et al. Among authors: philip i, philip t. Mol Biother. 1990 Mar;2(1):32-7. Mol Biother. 1990. PMID: 2185792 Clinical Trial.

3

Analysis of parameters for maximal in vitro proliferation and activation of lymphokine-activated killer cells (LAK).

Coze C, Combaret V, Philip I, Négrier S, Colin C, Gaspard M, Franks CR, Bijman JT, Philip T, Favrot M. Coze C, et al. Among authors: philip i, philip t. Nouv Rev Fr Hematol (1978). 1989;31(5):339-43. Nouv Rev Fr Hematol (1978). 1989. PMID: 2587202

4

Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients.

Philip T, Mercatello A, Negrier S, Philip I, Rebattu P, Kaemmerlin P, Gaspard M, Tognier E, Combaret V, Bijmann JT, et al. Philip T, et al. Among authors: philip i. Cancer Treat Rev. 1989 Jun;16 Suppl A:91-104. doi: 10.1016/0305-7372(89)90028-5. Cancer Treat Rev. 1989. PMID: 2788510

5

[Value of immunological analysis for the detection of residual neuroblasts in the bone marrow].

Combaret V, Favrot MC, Bailly C, Philip I, Zucker JM, Philip T. Combaret V, et al. Among authors: philip i, philip t. Bull Cancer. 1988;75(1):79-82. Bull Cancer. 1988. PMID: 3282577 French.

6

Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinoma.

Favrot MC, Combaret V, Negrier S, Philip I, Thiesse P, Freydel C, Bijmann JT, Franks CR, Mercatello A, Philip T. Favrot MC, et al. Among authors: philip i, philip t. J Biol Response Mod. 1990 Apr;9(2):167-77. J Biol Response Mod. 1990. PMID: 1971303

7

[Adoptive immunotherapy with interleukin 2 in oncology].

Favrot M, Bouffet E, Négrier S, Combaret V, Philip I, Philip T. Favrot M, et al. Among authors: philip i, philip t. Bull Cancer. 1990;77(9):925-31. Bull Cancer. 1990. PMID: 2224165 Clinical Trial. French.

8

Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.

Favrot MC, Philip I, Philip T, Portoukalian J, Doré JF, Lenoir GM. Favrot MC, et al. Among authors: philip i, philip t. J Natl Cancer Inst. 1984 Oct;73(4):841-7. J Natl Cancer Inst. 1984. PMID: 6592381

9

Use of a liquid cell culture assay to quantify the elimination of Burkitt lymphoma cells from the bone marrow.

Philip I, Favrot MC, Philip T. Philip I, et al. Among authors: philip t. J Immunol Methods. 1987 Feb 26;97(1):11-7. doi: 10.1016/0022-1759(87)90099-8. J Immunol Methods. 1987. PMID: 3029226

10

Experimental evaluation of an immunomagnetic bone marrow purging procedure using the Burkitt lymphoma model.

Favrot M, Philip I, Combaret V, Maritaz O, Philip T. Favrot M, et al. Among authors: philip i, philip t. Bone Marrow Transplant. 1987 Jun;2(1):59-66. Bone Marrow Transplant. 1987. PMID: 3332158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters